Target
Nuclear receptor ROR-gamma [262-507]
Ligand
BDBM268420
Substrate
n/a
Meas. Tech.
Nuclear receptor ROR-gamma
Temperature
298.15±n/a K
EC50
4400±n/a nM
Comments
extracted
Citation
 Fauber, BGobbi, A Keto-imidazopyridine derivatives as RORc modulators US Patent  US9550771 Publication Date 1/24/2017 
Target
Name:
Nuclear receptor ROR-gamma [262-507]
Synonyms:
NR1F3 | Nuclear receptor ROR-gamma | Nuclear receptor ROR-gamma (aa 262-507) | ROR-gamma (A262-S507) | RORC | RORG | RORG_HUMAN | RZRG
Type:
Enzyme Catalytic Domain
Mol. Mass.:
28605.37
Organism:
Homo sapiens (Human)
Description:
aa 262-507
Residue:
246
Sequence:
APYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS
  
Inhibitor
Name:
BDBM268420
Synonyms:
4-[1-(2-fluoro-6-methoxy- benzoyl)-5,6,7,8- tetrahydroimidazo[1,5-a]pyridin- 3-yl]benzoic acid | US9550771, Example 19
Type:
Small organic molecule
Emp. Form.:
C22H19FN2O4
Mol. Mass.:
394.3957
SMILES:
COc1cccc(F)c1C(=O)c1nc(-c2ccc(cc2)C(O)=O)n2CCCCc12
Structure:
Search PDB for entries with ligand similarity: